Header Logo

Connection

WILLIAM K PLUNKETT JR to Acenaphthenes

Back to Details
This is a "connection" page, showing publications WILLIAM K PLUNKETT JR has written about Acenaphthenes.
WILLIAM K PLUNKETT JR
Connection Strength
0.119
Acenaphthenes
  1. Phase I clinical, pharmacokinetic, and pharmacodynamic study of the Akt-inhibitor triciribine phosphate monohydrate in patients with advanced hematologic malignancies. Leuk Res. 2013 Nov; 37(11):1461-7.
    View in: PubMed
    Score: 0.119
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.